21 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
additional capital;
risks and uncertainties associated with supply chain issues caused by global and regional disruptions; and
other factors beyond … was delayed due to COVID-19-related shutdowns across the supply chain. The Company proceeded to produce its first samples of the commercial-grade
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
and uncertainties associated with supply chain issues caused by global and regional disruptions; and
other factors beyond the Company's control … to COVID-19-related shutdowns across the supply chain. The Company proceeded to produce its first samples of the commercial-grade prototypes in Q2 2021
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
and uncertainties associated with the Company's ability to raise additional capital;
risks and uncertainties associated with supply chain issues caused by global … prototypes were ordered into production in early 2020. This production run was delayed due to COVID-19-related shutdowns across the supply chain
6-K
EX-99.5
REPCF
Replicel Life Sciences Inc.
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
COVID related supply chain difficulties but is now in the final phase of product validation testing. “The Monasterium and Innovacell data illustrate
6-K
EX-99.2
erszjw1ilqqpj0xfj3
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
20-F/A
tpkxngv7
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
inm46
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.4
c00 skit7dax1g7aq3el
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.2
oo3c8zgaabp3x
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
llpa9 apgmw2hxxui459
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
0vl8z1g6h0l 812c5w
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
q8bes2inc
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.3
of4cj9m kv9vj9y78
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
sge19129rsrnz6
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.2
25oqatcufdmglnb2ph4
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm
6-K
EX-99.2
ac42ako858n520b0x3pq
3 Aug 20
Consolidated Financial Statements
12:00am